Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia

Proceedings of the National Academy of Sciences of the United States of America

Volumn 104, Issue 13, 2007, Pages 5431-5436

  Parmar, Kalindi ^a,c   Mauch, Peter ^a   Vergilio, Jo Anne ^a   Sackstein, Robert ^a   Down, Julian D ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Genetix Pharmaceuticals   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Gradient pimonidazole; Hoechst perfusion; Niche oxygen; Stem cell; Tirapazamine

Indexed keywords

HOE 33342; PIMONIDAZOLE; TIRAPAZAMINE; BENZIMIDAZOLE DERIVATIVE; NITROIMIDAZOLE DERIVATIVE; OXYGEN; TRIAZINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; CELL ISOLATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE DISTRIBUTION; TISSUE OXYGENATION; ANIMAL; ANOXIA; BONE MARROW CELL; C57BL MOUSE; CELL DIFFERENTIATION; CYTOLOGY; HEMATOPOIETIC SYSTEM; METABOLISM; PERFUSION; STEM CELL;

ANIMALS; ANOXIA; BENZIMIDAZOLES; BONE MARROW CELLS; CELL DIFFERENTIATION; HEMATOPOIETIC STEM CELLS; HEMATOPOIETIC SYSTEM; MICE; MICE, INBRED C57BL; NITROIMIDAZOLES; OXYGEN; PERFUSION; STEM CELLS; TRIAZINES;

EID: 34248359065     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0701152104     Document Type: Article

References (46)

1. Schofield R (1978) Blood Cells 4:7-25.
2. Weissman IL, Anderson DJ, Gage F (2001) Annu Rev Cell Dev Biol 17:387-403.
3. Lord BI (1990) Int J Cell Cloning 8:317-331.
4. Nilsson SK, Johnston HM, Coverdale JA (2001) Blood 97:2293-2299.
5. Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC, Martin RP, Schipani E, Divieti P, Bringhurst FR, et al. (2003) Nature 425:841-846.
6. Zhang J, Niu C, Ye L, Huang H, He X, Tong WG, Ross J, Haug J, Johnson T, Feng JQ, et al. (2003) Nature 425:836-841.
7. Arai F, Hirao A, Ohmura M, Sato H, Matsuoka S, Takubo K, Ito K, Koh GY, Suda T (2004) Cell 118:149-161.
8. Thomlinson RH, Gray LH (1955) Br J Cancer 9:539-549.
9. Brown JM, Wilson WR (2004) Nat Rev Cancer 4:437-447.
10. Harris AL (2002) Nat Rev Cancer 2:38-47.
11. Danet GH, Pan Y, Luongo JL, Bonnet DA, Simon MC (2003) J Clin Invest 112:126-135.
12. Cipolleschi MG, Dello Sbarba P, Olivotto M (1993) Blood 82:2031-2037.
13. Ivanovic Z, Dello Sbarba P, Trimoreau F, Faucher JL, Praloran V (2000) Transfusion 40:1482-1488.
14. Chow DC, Wenning LA, Miller WM, Papoutsakis ET (2001) Biophys J 81:685-696.
15. van Laarhoven HW, Bussink J, Lok J, Punt CJ, Heerschap A, van Der Kogel AJ (2004) Int J Radiat Oncol Biol Phys 60:310-321.
16. Bernsen HJ, Rijken PF, Peters H, Raleigh JA, Jeuken JW, Wesseling P, van der Kogel AJ (2000) J Neurosurg 93:449-454.
17. Durand RE, Chaplin DJ, Olive PL (1990) Methods Cell Biol 33:509-518.
18. Olive PL, Durand RE, Raleigh JA, Luo C, Aquino-Parsons C (2000) Br J Cancer 83:1525-1531.
19. Olive PL, Luo CM, Banath JP (2002) Br J Cancer 86:429-435.
20. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC (1996) J Exp Med 183:1797-1806.
21. Parmar K, Sauk-Schubert C, Burdick D, Handley M, Mauch P (2003) Exp Hematol 31:244-250.
22. Goodell MA, Rosenzweig M, Kim H, Marks DF, DeMaria M, Paradis G, Grupp SA, Sieff CA, Mulligan RC, Johnson RP (1997) Nat Med 3:1337-1345.
23. Matsuzaki Y, Kinjo K, Mulligan RC, Okano H (2004) Immunity 20:87-93.
24. Pearce DJ, Ridler CM, Simpson C, Bonnet D (2004) Blood 103:2541-2546.
25. Hale LP, Braun RD, Gwinn WM, Greer PK, Dewhirst MW (2002) Am J Physiol 282:H1467-H1477.
26. Raleigh JA, Dewhirst MW, Thrall DE (1996) Semin Radiat Oncol 6:37-45.
27. Down JD, Ploemacher RE (1993) Exp Hematol 21:913-921.
28. Down JD, Boudewijn A, van Os R, Thames HD, Ploemacher RE (1995) Blood 86:122-127.
29. Ploemacher RE, van der Sluijs JP, Vocrman JS, Brons NH (1989) Blood 74:2755-2763.
30. Ploemacher RE, van der Sluijs JP, van Beurden CA, Baert MR, Chan PL (1991) Blood 78:2527-2533.
31. Holden SA, Teicher BA, Ara G, Herman TS, Coleman CN (1992) J Natl Cancer Inst 84:187-193.
32. Papadopoulou MV, Ji M, Ji X, Bloomer WD (2002) Cancer Chemother Pharmacol 50:291-298.
33. Gallagher R, Hughes CM, Murray MM, Friery OP, Patterson LH, Hirst DG, McKeown SR (2001) Br J Cancer 85:625-629.
34. Stier S, Ko Y, Forkert R, Lutz C, Neuhaus T, Grunewald E, Cheng T, Dombkowski D, Calvi LM, Rittling SR, Scadden DT (2005) J Exp Med 201:1781-1791.
35. Nilsson SK, Johnston HM, Whitty GA, Williams B, Webb RJ, Denhardt DT, Bertoncello I, Bendall LJ, Simmons PJ, Haylock DN (2005) Blood 106:1232-1239.
36. Kiel MJ, Yilmaz OH, Iwashita T, Yilmaz OH, Terhorst C, Morrison SJ (2005) Cell 121:1109-1121.
37. Unwin RD, Smith DL, Blinco D, Wilson CL, Miller CJ, Evans CA, Jaworska E, Baldwin SA, Barnes K, Pierce A, et al. (2006) Blood 107:4687-4694.
38. Camargo FD, Chambers SM, Drew E, McNagny KM, Goodell MA (2006) Blood 107:501-507.
39. Zhou S, Schuetz JD, Bunting KD, Colapietro AM, Sampath J, Morris JJ, Lagutina I, Grosveld GC, Osawa M, Nakauchi H, Sorrentino BP (2001) Nat Med 7:1028-1034.
40. Krishnamurthy P, Ross DD, Nakanishi T, Bailey-Dell K, Zhou S, Mercer KE, Sarkadi B, Sorrentino BP, Schuetz JD (2004) J Biol Chem 279:24218-24225.
41. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, Capla JM, Galiano RD, Levine JP, Gurtner GC (2004) Nat Med 10:858-864.
42. Nishi H, Nakada T, Kyo S, Inoue M, Shay JW, Isaka K (2004) Mol Cell Biol 24:6076-6083.
43. Yatabe N, Kyo S, Maida Y, Nishi H, Nakamura M, Kanaya T, Tanaka M, Isaka K, Ogawa S, Inoue M (2004) Oncogene 23:3708-3715.
44. Covello KL, Kehler J, Yu H, Gordan JD, Arsham AM, Hu CJ, Labosky PA, Simon MC, Keith B (2006) Genes Dev 20:557-570.
45. Gustafsson MV, Zheng X, Pereira T, Gradin K, Jin S, Lundkvist J, Ruas JL, Poellinger L, Lendahl U, Bondesson M (2005) Dev Cell 9:617-628.
46. Sipkins DA, Wei X, Wu JW, Runnels JM, Cote D, Means TK, Luster AD, Scadden DT, Lin CP (2005) Nature 435:969-973.